Benjamin A Rogers (B A Rogers, Benjamin Rogers, Ben Rogers)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Systematic Review

Top Venues

The Journal of antimicrobial chemotherapy

Open forum infectious diseases

JAC-antimicrobial resistance

This page only lists publications with an associated author ORCID identifier.

Publications

Fiona Clarke, Adelaide Grenfell, Sarah Chao, Helen Richards, Tony Korman, Benjamin A Rogers
Use of echinocandin outpatient parenteral antimicrobial therapy for the treatment of infection caused by Candida spp.: utilization, outcomes and impact of a change to weekly dosing. The Journal of antimicrobial chemotherapy (2024)
Christopher Robson, Bryan Tan, Rhonda Stuart, Stephen Nicholls, Benjamin A Rogers, Indy Sandaradura
A systematic review of optimal pharmacokinetic/pharmacodynamic parameters for beta-lactam therapy in infective endocarditis. The Journal of antimicrobial chemotherapy (2023)
Benjamin A Rogers, Robert Fowler, Patrick N A Harris, Joshua S Davis, Ruxandra L Pinto, Dhiraj Bhatia Dwivedi, Asgar Rishu, Yahya Shehabi, Nick Daneman
Non-inferiority trial of a shorter (7 days) compared with a longer (14 days) duration of antimicrobial therapy for the treatment of bacteraemic urinary sepsis, measured by microbiological success after the completion of therapy: a substudy protocol for the Bacteraemia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE) multicentre randomised controlled trial. BMJ open 13 (6) (2023)
L Kalatharan, M Ferman, S Kumar, S Rajendra, S Pripanapong, Y Wu, H Richards, Benjamin A Rogers
Use of Ceftriaxone and Benzylpenicillin in Outpatient Parenteral Antimicrobial Therapy: Spectrum vs Cost. Open forum infectious diseases 10 (11) (2023)
Amy Legg, Matthew A Roberts, Jane Davies, Alan Cass, Niamh Meagher, Archana Sud, Vered Daitch, Yael Dishon Benattar, Dafna Yahav, Mical Paul, Chen Xinxin, Yeo He Ping, David Lye, Russel Lee, J Owen Robinson, Hong Foo, Adrian R Tramontana, Narin Bak, Adelaide Grenfell, Benjamin A Rogers, Ying Li, Neela Joshi, Matthew O'Sullivan, Genevieve McKew, Niladri Ghosh, Kellie Schneider, Natasha E Holmes, Ravindra Dotel, Timothy Chia, Sophia Archuleta, Simon Smith, Morgyn S Warner, Christina Titin, Shirin Kalimuddin, Jason Alexander Roberts, Steven Y C Tong, Joshua Saul Davis, null null
Longer-term Mortality and Kidney Outcomes of Participants in the Combination Antibiotics for Methicillin-Resistant Staphylococcus aureus (CAMERA2) Trial: A Post Hoc Analysis. Open forum infectious diseases 10 (7) (2023)
Kwadwo Mponponsuo, Ruxandra Pinto, Robert Fowler, Benjamin A Rogers, Nick Daneman
Fixed versus individualized treatment for five common bacterial infectious syndromes: a survey of the perspectives and practices of clinicians. JAC-antimicrobial resistance 5 (4) (2023)
Benjamin A Rogers, Robert Fowler, Patrick N A Harris, Joshua S Davis, Ruxandra L Pinto, Dhiraj Bhatia Dwivedi, Asgar Rishu, Yahya Shehabi, Nick Daneman
Non-inferiority trial of a shorter (7 days) compared with a longer (14 days) duration of antimicrobial therapy for the treatment of bacteraemic urinary sepsis, measured by microbiological success after the completion of therapy: a substudy protocol for the Bacteraemia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE) multicentre randomised controlled trial. BMJ open 13 (6) (2023)
Benjamin A Rogers, Robert Fowler, Patrick N A Harris, Joshua S Davis, Ruxandra L Pinto, Dhiraj Bhatia Dwivedi, Asgar Rishu, Yahya Shehabi, Nick Daneman
Non-inferiority trial of a shorter (7 days) compared with a longer (14 days) duration of antimicrobial therapy for the treatment of bacteraemic urinary sepsis, measured by microbiological success after the completion of therapy: a substudy protocol for the Bacteraemia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE) multicentre randomised controlled trial. BMJ open 13 (6) (2023)
Christopher Robson, Bryan Tan, Rhonda Stuart, Stephen Nicholls, Benjamin A Rogers, Indy Sandaradura
A systematic review of optimal pharmacokinetic/pharmacodynamic parameters for beta-lactam therapy in infective endocarditis. The Journal of antimicrobial chemotherapy 78 (3) (2023)